1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Philippines Pharmaceuticals and Healthcare Report Q4 2015

Philippines Pharmaceuticals and Healthcare Report Q4 2015

  • September 2015
  • -
  • Business Monitor International
  • -
  • 132 pages

Includes 3 FREE quarterly updates

BMI View: The proposed 2016 government budget will be positive for the Philippines healthcare sector.The budget proposes a significant increase in funds allocated to the Department of Health which willenable authorities to finance the expansion of the country's health insurance scheme and upgrade medicalfacilities in the country. These two thrusts collectively address some of the key impediments to healthcareaccess in the Philippines and will reinforce commercial opportunities for pharmaceutical companiesoperating in the country. However, further price caps on high-value medicines and poor intellectualproperty protection continue to pose a substantial risk for multinational drugmakers.

Headline Expenditure Projections

- Pharmaceuticals: PHP145.05bn (USD3.28bn) in 2014, rising to PHP150.49bn (USD3.32bn) in 2015;+3.8% in local currency terms and +1.0% in US dollar terms. Forecast revised upwards from lastquarter.

- Healthcare: PHP563.49bn (USD12.75bn) in 2014, rising to PHP623.75bn (USD13.74bn) in 2015;+10.7% in local currency terms and +7.8% in US dollar terms. Revised downwards from last quarter.

Table Of Contents

Philippines Pharmaceuticals and Healthcare Report Q4 2015
BMI Industry View 7
SWOT 10
Political 12
Economic 13
Operational Risk 14
Industry Forecast 16
Pharmaceutical Market Forecast 16
Table: Pharmaceutical Sales, Historical Data And Forecasts (Philippines 2011-2019) 19
Healthcare Market Forecast 19
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Philippines 2011-2019) 21
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Philippines 2011-2019) 22
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Philippines 2011-2019) 22
Prescription Drug Market Forecast 22
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Philippines 2011-2019) 24
Patented Drug Market Forecast 25
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Philippines 2011-2019) 27
Generic Drug Market Forecast 27
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Philippines 2011-2019) 30
OTC Drug Market Forecast 31
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Philippines 2011-2019) 33
Pharmaceutical Trade Forecast 33
Table: Pharmaceutical Trade Data And Forecasts (Philippines 2013-2019) 36
Table: Pharmaceutical Trade Data And Forecasts local currency (Philippines 2013-2019) 37
Key Risks To BMI's Forecast Scenario 37
Macroeconomic Forecasts 39
Economic Analysis 39
Table: Economic Activity (Philippines 2010-2019) 43
Industry Risk Reward Indices 44
Asia Pacific Risk/Reward Index 44
Philippines Risk/Reward Index 50
Rewards 50
Risks 51
Market Overview 52
Industry Trends And Developments 53
Epidemiology 53
Healthcare Sector 55
Table: Healthcare Resources (Philippines 2009-2014) 59
Table: Healthcare Personnel (Philippines 2009-2014) 59
Table: Healthcare Activity (Philippines 2009-2014) 60
Health Insurance 60
Healthcare Sector Financing 62
Medical Tourism 63
Biotechnology And Research 63
Traditional Medicines 65
Clinical Trials 66
Regulatory Development 67
Table: History Of Food And Drugs Administration 68
Intellectual Property Regime 73
Pricing Regime 77
Table: Medicines Subject To March 31 2010 Government Mediated Access Price 82
Reimbursement Regime 83
International Cooperation 83
Competitive Landscape 85
Pharmaceutical Industry 85
Table: Pharmaceutical Industry Overview 85
Domestic Pharmaceutical Industry 85
Pharmaceutical Distribution And Retail 87
Table: Overview Of BnB, BNB and P100 Programme 92
Table: Cost Of Generic Drugs In Philippines (PHP) 92
Table: Number Of BnBs And BNBs In Selected Philippine Regions 93
Company Profile 94
GlaxoSmithKline Philippines 94
MediChem Pharmaceuticals 97
Merck and Co 99
Novartis 101
Pacific Pharmaceutical Generics 105
Pascual Laboratories 107
Pfizer 110
Sanofi 114
Unilab 118
Demographic Forecast 121
Table: Population Headline Indicators (Philippines 1990-2025) 122
Table: Key Population Ratios (Philippines 1990-2025) 122
Table: Urban/Rural Population and Life Expectancy (Philippines 1990-2025) 123
Table: Population By Age Group (Philippines 1990-2025) 123
Table: Population By Age Group % (Philippines 1990-2025) 124
Glossary 126
Methodology 128
Pharmaceutical Expenditure Forecast Model 128
Healthcare Expenditure Forecast Model 128
Notes On Methodology 129
Risk/Reward Index Methodology 130
Index Overview 131
Table: Pharmaceutical Risk/Reward Index Indicators 131
Indicator Weightings 132

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Prostate Cancer Pricing, Reimbursement, and Access

Prostate Cancer Pricing, Reimbursement, and Access

  • $ 7 500
  • Industry report
  • July 2016
  • by Datamonitor Healthcare

Novel antiandrogens will need to present risk-sharing agreements in EU markets, while discussing contracting with US payers to ensure a competitive advantage. Vaccines suffer from inconclusive response ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7 000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...

IMS World Review Executive™ 2016

IMS World Review Executive™ 2016

  • $ 6 860
  • Industry report
  • July 2016
  • by IMS Health

IMS World Review ExecutiveTM 2016 provides essential insights into worldwide sales of the pharmaceutical market, interlocking market trends and sales analysis from 2011 to 2015, including the breakdown ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.